Medication Treatments | Addiction Professional Magazine Skip to content Skip to navigation

Medication Treatments

Stigma apparent in physician replies to survey on buprenorphine prescribing

August 8, 2017  |  Gary A. Enos, Editor
article
A 2016 physician survey on the prescribing of buprenorphine does indicate that counselors and other specialty providers could help physicians overcome reluctance to prescribe the opioid dependence treatment.

Rapid-access clinics reduce emergency department visits in Ontario

July 25, 2017  |  Tom Valentino, Senior Editor
article
Seven rapid-access clinics in Ontario are providing a transition between emergency departments and primary care in the treatment of opioid and alcohol addictions.

Marrying science and design to improve access to naloxone

July 24, 2017  |  Gary A. Enos, Editor
blog
University professors used their collective talents to create a device allowing easy access to the opioid overdose reversal drug naloxone.

Three keys to lowering mortality rates in opioid disorder patients

July 21, 2017  |  Alison Knopf, Contributing Writer
article
New research has found that providing psychosocial counseling and avoiding prescribed opioids or benzodiazepines are among the variables that can reduce mortality rates in opioid use disorders. Medication treatment did not affect death rates.

ADHD patients' substance use risk lower in medicated periods

July 17, 2017  |  Gary A. Enos, Editor
news
Researchers have found that individuals with attention-deficit/hyperactivity disorder (ADHD) are at lower risk of alcohol or drug abuse when they are taking ADHD medications.

Report offers state-by-state breakdown of non-medical prescription drug use

July 14, 2017  |  Gary A. Enos, Editor
news
A new report from the Substance Abuse and Mental Health Services Administration (SAMHSA) shows that the prevalence of non-medical use of prescription opioids in 2012-2014 was highest in Oklahoma and lowest in Minnesota.

Partnership in R.I. will accelerate buprenorphine training

July 13, 2017  |  Gary A. Enos, Editor
article
An expanded addictions curriculum in Brown University's medical school will allow some young doctors to qualify immediately to prescribe buprenorphine for opioid dependence.

Drug maker agrees to stop selling Opana ER because of misuse

July 7, 2017  |  Julie Miller, Editor in Chief
news
Endo Pharmaceuticals on Thursday agreed to remove its long-acting Opana ER pain drug from the market, following an FDA request that it stop selling the product because of incidents of misuse.

Place medication in the rightful context

June 27, 2017  |  Gary A. Enos, Editor
blog
A number of experts in the addiction field would like to see use of the term "medication-assisted treatment" eradicated, saying that it perpetuates stigma.

Patients benefit from having voice in treatment planning

June 26, 2017  |  Tom Valentino, Senior Editor
article
Engaging clients in dialogue during treatment planning and implementation can improve the odds of better outcomes, Robert Matylewicz, DO, FASAM, medical director at Clarity Way Inc., told attendees of the Summit for Clinical Excellence event Monday in...

Few young people with opioid dependence have received medication

June 21, 2017  |  Gary A. Enos, Editor
news
A Boston Medical Center study has found that just over one-quarter of adolescents and young adults diagnosed with an opioid use disorder from 2001-2014 received a prescription for buprenorphine or naltrexone.

AATOD leader among Faces & Voices honorees

June 20, 2017  |  Gary A. Enos, Editor
news
Mark Parrino of the American Association for the Treatment of Opioid Dependence (AATOD) will receive the Lisa Mojer-Torres Award next month from Faces & Voices of Recovery.

Pages

Subscribe to Medication Treatments